Analysis, Commentary 08.10.2018
States Are Not Waiting on Congress to Expand Medicare to Cover Everybody
Which one will be first?
Which one will be first?
The “fear, uncertainty and doubt” campaign against “Medicare for all” is on.
Insurance company CEOs and their shareholders, thats who.
Studies show life expectancy in the United States is going down while it continues to go up in other developed countries.
Donna Smith, a major force behind expanding the U.S. health care system, is hanging up her hat.
I’ve been asked many times if there was one thing, one moment, that led me to leave my job at a big health insurance corporation. Yes, there was, and it occurred five days before Christmas in 2007.
“We need to give the criminal purveyors of these products no quarter,” Scott Gottlieb, FDA Commissioner, said.
As the support for a single-payer, “Medicare-for-All” health care system in U.S. grows, so do the contributions from the health insurance industry.
What Americans earn and save and how much they’re in debt varies wildly, but where you live — and the overall health of the economy there — could be a factor in how the next recession impacts you. Check our map to see how your home state is doing.
What we found: Banks are using their influence on Congress to lighten their paperwork, but some of that paperwork was helping to protect America’s economy.
What you can do: Follow Tarbell to track the risks of easing rules for financial institutions—and prepare for the next recession.
Two things you can do, and three ways government might help to survive the next economic slump.
A Tarbell story has led to a call for a Department of Justice investigation by a top Florida lawmaker.
Unable to afford U.S. drug prices, patients have long filled their prescriptions by ordering cheaper drugs from overseas. Now, the Food and Drug Administration is dramatically increasing how many of those shipments are stopped at the border.
The story of the great lengths the health insurance industry went to blunt the impact of Michael Moore’s SiCKO and turn public opinion against him.
All Mayor Jim Kenney wanted to do was give underprivileged North and West Philadelphia kids a chance and pay for it with soda pop. So why is that tearing the city apart?
Most experts predict the next recession will hit America in 2020. Are you ready?
Take our survey.
You’re not alone in wanting to fix a broken system that perpetuates high prices.
What we found: Drug stores and hospitals cloak the profits they make on your medications in complex contracts and confusing billing.
What you can do: Seek out the cash price for your prescription. Often it will be cheaper than your copay.
What we learned: The arrangements between drug manufacturers and insurance middlemen are accelerating price increases.
What you can do: Support new proposals to bring transparency to the drug pricing system.
6 ways to combat high drug prices and fight for transparency in our drug supply chain.
What we learned: The US drug supply chain is designed to keep prices high – and you in the dark.
What you can do: Find cheaper prices for your prescriptions and check out new nonprofit drug companies trying to bring costs down.
Across the country, expanding the dental workforce to include dental therapists is one of a very few health care proposals that attracts support from lawmakers in both parties.
Yes, Novartis secretly paid Trump lawyer Michael Cohen $1.2 million to gain insights into the president’s thinking on health care. But there is more to it.
Thirty-six state attorneys general and others allege that the manufacturer of Suboxone, a balm for America’s opioid crisis, gamed regulators and manipulated the market to overcharge consumers.
The drug industry worked with the Obama administration to sow safety fears about cheaper medications from foreign sources.
6 ways you can spot biased research and help expose false findings.
Many organizations demand transparency about funders and authors of industry-backed studies.
What we learned: Why you should be concerned some scientists bias their results to benefit their corporate funders over the public welfare.
What you can do: Join Tarbell in finding false, industry-funded research.
What we learned: Research funded by companies pervades government policy making and regulatory agencies. Slanted and misleading data has a long history of helping corporate bottom lines while endangering public health and welfare.
What you can do: Learn to spot a suspect study by asking the right five questions.
What we learned: How to spot research that is biased to support corporate profits over people.
What you can do: Educate yourself by researching how products you use, like prescription drugs, have caused harm to others.